- Form 8.3 - Renalytix plc
- Form 8.5 (EPT/RI) - Renalytix plc
- Block Admission & “At The Market†Sales Agreement
- Form 8.3 - Renalytix PLC
- Form 8.3 - Renalytix plc
- Form 8.5 (EPT/NON-RI) - RENALYTIX
- Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
- Renalytix Reports Financial Results for Q3 FY2024
- Holding(s) in Company
- Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
More ▼
Key statistics
On Thursday, Renalytix PLC (RENX:LSE) closed at 19.50, 95.00% above the 52 week low of 10.00 set on Feb 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.50 |
---|---|
High | 23.00 |
Low | 23.00 |
Bid | 19.00 |
Offer | 22.00 |
Previous close | 19.50 |
Average volume | 163.05k |
---|---|
Shares outstanding | 154.37m |
Free float | 95.31m |
P/E (TTM) | -- |
Market cap | 30.08m GBP |
EPS (TTM) | -0.445 GBP |
Data delayed at least 20 minutes, as of May 23 2024 14:55 BST.
More ▼
Investors Chronicle View
The last IC recommendation on Renalytix PLC shares was Buy at 878.00 on 21 Oct 2021Read the full article